CureVac files expanded patent lawsuit against Pfizer/BioNTech over mRNA technology
New Delhi: CureVac NV said on Friday it had filed an expanded patent infringement claim against Pfizer Inc and BioNTech
Read moreNew Delhi: CureVac NV said on Friday it had filed an expanded patent infringement claim against Pfizer Inc and BioNTech
Read moreNew Delhi: Pfizer Ltd, the Indian unit of US drug maker Pfizer Inc has suspended sale and use of its
Read moreNew Delhi: The combination of AstraZeneca‘s cancer drug, Tagrisso, with chemotherapy to treat patients with a type of lung cancer
Read moreSeveral controversial issues, as per the industry sources, including pricing of patented drugs, rationalisation of trade margins, adopting a uniform
Read moreLondon: AstraZeneca has decided to leave the main US drug lobby group, the Pharmaceutical Research and Manufacturers of America (PhRMA),
Read moreNew Delhi: Two companies are conducting trials to develop a dengue vaccine, Director General, Indian Council of Medical Research Dr
Read moreTo support our investor community, govt has also approved the establishment of four medical device parks in the states. These
Read moreNew Delhi: India‘s drug regulator has proposed testing cough syrups in government laboratories before they are exported, a media outlet
Read more